JCOG0603: Are We Really Sure This Was a Negative Trial?
Auteurs : Saude Conde R, Bregni G, Saad E, Hendlisz A, Sclafani F Jaar : 2022 Journal : J Clin Oncol
Deep Epigastric Lymph Nodes Implication in Patients' Recurrence Pattern After Cytoreductive Surgery in Colorectal Peritoneal Metastases.
Auteurs : El Asmar A, Vouche M, Galdon MG, Bali MA, Sclafani F, Donckier V, Liberale G Jaar : 2022 Journal : J Gastrointest Surg
ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective.
Auteurs : Koessler T, Alsina M, Arnold D, Ben-Aharon I, Collienne M, Lutz MP, Neuzillet C, Obermannova R, Peeters M, Sclafani F, Smyth E, Valle JW, Wagner AD, Wyrwicz L, Fontana E, Moehler M Jaar : 2022 Journal : ESMO Open
Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.
Auteurs : Bregni G, Vandeputte C, Pretta A, Senti C, Trevisi E, Acedo Reina E, Kehagias P, Liberale G, Moretti L, Bali MA, Demetter P, Flamen P, Carrasco J, DHondt L, Geboes K, Gokburun Y, Peeters M, Van den Eynde M, Van Laethem JL, Vergauwe P, Chapot CA, Buyse M, Deleporte A, Hendlisz A, Sclafani F Jaar : 2021 Journal : Acta oncol (Stockholm)
Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer.
Auteurs : Wrona E, Potemski P, Sclafani F, Borowiec M Jaar : 2021 Journal : Arch Immunol Ther Exp (Warsz)